Major win for Aussies slugged with $950 medical bills: ‘Don't get hit by unexpected fees'
Aussies across the country can pay hundreds of dollars more than their neighbours for the same procedure, with fees varying hugely from specialist to specialist. In Perth, for example, the average out-of-pocket cost for cataract surgery is $190 but some have paid less than $20 and others paid more than $500 for the same operation.
Aussies in central Sydney who have undergone colonoscopies can pay as little as $20, or more than $680, even though the average cost is about $280.
RELATED
Health insurance premium price hike for 15 million Aussies revealed: 'Caught in crossfire'
Centrelink cash boost to hit accounts this week: 'Critical'
$800,000 Centrelink 'hack' for Bank of Mum and Dad to avoid pension cut
The Medical Costs Finder Website allows patients to see the average fee charged by every eligible non-GP specialist and compare it with the national average for that service.
The $24 million website was launched by the former Coalition government in 2019 but since then less than 100 of 11,000 medical specialists have voluntarily uploaded their fees to the site.
Health Minister Mark Butler will announce the review of the website today and said the service had been 'left gathering dust' and wasn't currently helping patients work out out-of-pocket costs.
'The Albanese Labor government will help Australians find the best value when they need specialist medical advice and treatment, by upgrading the Medical Costs Finder to give more transparency on fees,' Butler said.
The improved website would include data from private health insurers showing their financial arrangements with specialists and how often patients have to pay out-of-pocket costs.
The website will also analyse annual data from Medicare, hospitals and insurers to improve the website's information.
It comes after the government announced it would deliver a $8.5 billion funding boost to Medicare if re-elected, which it said would lead to nine out of 10 GP visits being bulk billed by 2030.The move has been welcomed by medical and private health insurance bodies.
The Australian Medical Association (AMA) said it would work with the government on upgrades to the website to ensure all information is available and existing challenges are addressed.
AMA president Dr Danielle McMullen said the group had 'long advocated for greater transparency for patients when it comes to medical costs'.
McMullen noted a major challenge to uptake was the lack of information provided by private health insurers, particularly about rebates provided for specific procedures.
Private Healthcare Australia said health funds would work with the government to help consumers get reliable quotes before they proceeded with medical treatment in the private health system.
'This is a massive win for consumers who have been crying out for more information and competition between specialist doctors, so they don't get hit by unexpected fees,' CEO Dr Rachel David said.
'While most doctors charge appropriately, we know an increasing number of Australians have been charged exorbitant fees by specialist doctors, including more than $950 for first appointments with psychiatrists.'
The group said paying more did not guarantee better treatment or a better health outcome. It has called on the Opposition to match the commitment.Sign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
3 hours ago
- Business Wire
Echo and The Vitamin Outlet Partner: Bringing Hydrogen Water Health to Australians
SALT LAKE CITY & PERTH, Australia--(BUSINESS WIRE)-- Echo, a global leader in hydrogen health, has partnered with The Vitamin Outlet to launch the Echo Flask — now available to Australians seeking science-backed hydration. Echo has teamed up with The Vitamin Outlet to introduce the Echo Flask to Australia. This innovative, app-connected bottle infuses water with molecular hydrogen, offering a powerful antioxidant that supports energy, recovery, and overall cellular health. The Echo Flask is an app-connected bottle that infuses water with molecular hydrogen — a powerful antioxidant that supports energy, recovery, and cellular health. Its advanced PEM technology delivers up to 8 ppm in 20 minutes. 'We're proud to offer the Echo Flask to our customers,' said Kwong Keet Chan, CEO of The Vitamin Outlet. 'It represents a new class of hydration — safe, convenient, and scientifically validated. It fits into our mission to provide premium wellness solutions that Australians can trust.' Backed by peer-reviewed research, hydrogen water is gaining recognition for its potential to reduce oxidative stress and inflammation at the cellular level. The Echo Flask makes this wellness tool more accessible than ever. 'Australians are among the most engaged when it comes to preventative health,' said Josh Carr, CEO of Echo. 'Partnering with The Vitamin Outlet allows us to deliver an elite hydrogen wellness product to a market that values innovation and results.' Available for AUD $470, the Echo Flask is now offered through The Vitamin Outlet's website and at their Bull Creek location in Perth. Key Features of the Echo Flask Generates 5 ppm in 10 minutes, 8 ppm in 20 minutes Echo App for cycle control and hydration tracking Lightweight 350 ml design Smart touchscreen, USB-C charging Chemical-free PEM tech — no byproducts or contaminants A 5-year warranty About Echo Echo is a pioneer in hydrogen health, dedicated to helping people unlock and sustain peak performance by transforming water into a clean source of cellular support. From advanced home water systems to portable wellness solutions, Echo partners with the body to promote internal balance, resilience, and consistent energy. Backed by peer-reviewed science, trusted by health experts, and engineered for everyday living, Echo makes hydrogen health accessible, effective, and transformative. For more information, visit About The Vitamin Outlet With both an online platform and physical presence in Perth, The Vitamin Outlet is a go-to destination for trusted wellness products in Australia. It curates scientifically backed tools that help Australians live better, naturally — combining integrity, education, and service to meet the needs of today's informed consumer.
Health Line
a day ago
- Health Line
Medicare Coverage of Xiidra
Medicare may cover Xiidra (lifitegrast ophthalmic solution) if you have a plan with prescription drug coverage, such as a Part D plan or a Medicare Advantage (Part C) plan. Xiidra is a brand-name drug that doctors may prescribe to treat the symptoms of dry eye disease. Medicare and Xiidra Xiidra belongs to a group of drugs called a lymphocyte function-associated antigen-1 (LFA-1) antagonist. The drug is approved by the Food and Drug Administration (FDA) to treat the signs and symptoms of dry eye disease. To receive coverage for Xiidra, you need to have a Medicare prescription drug plan. If you have Original Medicare (parts A and B), you can enroll in a stand-alone Part D plan to cover your medications. If you have a Medicare Advantage plan, you likely have prescription drug coverage as part of your plan. However, not all Medicare Advantage plans include drug benefits. Private insurance companies offer Medicare drug plans, and their lists of covered drugs differ. Your plan will cover Xiidra if it's included in the plan's formulary. More than half of Medicare drug plans cover Xiidra. Review your plan's documentation or contact a representative to learn whether it covers Xiidra. If it does not, it may cover an alternative medication for dry eye disease. The Centers for Medicare & Medicaid Services (CMS) offers a coverage finder tool to allow users to find plans in their area that include coverage for Xiidra. Xiidra cost with Medicare The amount you pay for Xiidra will depend on a few factors. These include your location, your plan, and the drug's tier. Medicare prescription drug plans group covered drugs into cost tiers. Xiidra is typically a higher tier drug, with no generic version. The amount you pay for Xiidra will also depend on what stage of coverage you are in. In 2025, most Part D plans have three stages of coverage. Beneficiaries will have different out-of-pocket expenses depending on the stage: Deductible stage: If your plan has a deductible, you'll pay the full cost of the medication until you reach your deductible amount. In 2025, the maximum deductible amount for a Part D plan is $590. Initial coverage stage: After meeting your deductible, you'll pay a 25% coinsurance on the cost of covered medications until your out-of-pocket costs reach $2,000. Catastrophic stage: Once you've spent $2,000 in a calendar year, you'll pay no more for covered medications. If you qualify for cost assistance through the Extra Help program, your costs will be lower.
Health Line
a day ago
- Health Line
Medicare Coverage of Revlimid
Medicare may cover Revlimid (lenalidomide) if you have a plan with prescription drug coverage, such as a Part D plan or a Medicare Advantage (Part C) plan. Revlimid is a brand-name drug that doctors may prescribe to treat conditions including multiple myeloma and mantle cell lymphoma in certain adults. Medicare and Revlimid Revlimid is a type of drug called a thalidomide analogue. The drug is approved by the Food and Drug Administration (FDA) to treat the following conditions: myelodysplastic syndromes multiple myeloma marginal zone lymphoma follicular lymphoma mantle cell lymphoma To receive coverage for Revlimid, you must have a Medicare prescription drug plan. If you have Original Medicare (parts A and B), you can enroll in a stand-alone Part D plan to cover your medications. If you have a Medicare Advantage plan, it might cover prescription drugs. Not all Medicare Advantage plans include drug benefits. Private insurance companies offer Medicare drug plans, and their lists of covered drugs differ. Your plan will cover Revlimid if it's listed in their formulary. Most Medicare drug plans cover Revlimid. Review your plan's documentation or contact a representative to learn whether it covers Revlimid. If it does not, it may cover an alternative medication. The Centers for Medicare & Medicaid Services (CMS) offers a coverage finder tool to allow users to find plans in their area that include coverage for Revlimid. Revlimid cost with Medicare The amount you pay for Revlimid will depend on a few factors, including your location, your plan, and the drug's tier. Medicare prescription drug plans group covered drugs into cost tiers. Revlimid is typically a higher-tier drug, although it has generic version. According to Revlimid's manufacturer, the list price for the drug is $18,723 per 28-day cycle. The amount you pay for Revlimid will also depend on what stage of coverage you are in. In 2025, most Part D plans have three stages of coverage. Beneficiaries will have different out-of-pocket expenses depending on the stage: Deductible stage: If your plan has a deductible, you'll pay the full cost of the medication until you reach your deductible amount. In 2025, the maximum deductible amount for a Part D plan is $590. Initial coverage stage: After meeting your deductible, you'll pay a 25% coinsurance on the cost of covered medications until your out-of-pocket costs reach $2,000. Catastrophic stage: Once you've spent $2,000 in a calendar year, you'll pay no more for covered medications.
